Provided by Tiger Trade Technology Pte. Ltd.

LifeStance Health Group, Inc.

6.83
+0.29004.43%
Volume:2.63M
Turnover:17.78M
Market Cap:2.66B
PE:-291.42
High:6.87
Open:6.55
Low:6.46
Close:6.54
52wk High:8.30
52wk Low:3.74
Shares:389.00M
Float Shares:140.04M
Volume Ratio:1.56
T/O Rate:1.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0234
EPS(LYR):-0.1515
ROE:-0.62%
ROA:0.26%
PB:1.78
PE(LYR):-45.08

Loading ...

Should Analyst Revisions and 16% Revenue Growth Require Action From LifeStance Health Group (LFST) Investors?

Simply Wall St.
·
Feb 04

LifeStance Health Group Is Maintained at Buy by BTIG

Dow Jones
·
Feb 02

Insurer-Supported Access To Care Could Be A Game Changer For LifeStance Health Group (LFST)

Simply Wall St.
·
Jan 26

Lifestance Health Group (LFST) Receives a Buy from KeyBanc

TIPRANKS
·
Jan 08

Director Robert Bessler Reports Sale of LifeStance Health Group Inc. Common Shares

Reuters
·
Dec 24, 2025

Chief People Officer Ann Varanakis Reports Disposal of LifeStance Health Group Inc. Common Shares

Reuters
·
Dec 20, 2025

Director Robert Bessler Reports Sale of LifeStance Health Group Inc. Common Shares

Reuters
·
Dec 17, 2025

LifeStance Health Group Is Maintained at Buy by BTIG

Dow Jones
·
Dec 12, 2025

The Bull Case For LifeStance Health Group (LFST) Could Change Following New Wave Of Analyst Support

Simply Wall St.
·
Dec 11, 2025

LifeStance Health Group Initiated at Overweight by Barclays

Dow Jones
·
Dec 09, 2025

Barclays Initiates Lifestance Health With Overweight Rating, $8 Price Target

MT Newswires Live
·
Dec 09, 2025

LifeStance Health Group Inc. Officer Lisa K. Miller Reports Disposal of Common Shares

Reuters
·
Nov 26, 2025

A Look at LifeStance Health Group's (LFST) Valuation Following Upbeat Profitability and Guidance Shift

Simply Wall St.
·
Nov 24, 2025

Lifestance Health Q3 Revenue USD 363.8 Million Vs. IBES Estimate USD 355.6 Million

Reuters
·
Nov 20, 2025

A Look at LifeStance Health Group’s (LFST) Valuation Following Strong Q3 Results and Improved Margin Guidance

Simply Wall St.
·
Nov 13, 2025

BMO Capital Initiates Coverage on Lifestance Health With Outperform Rating, $8 Price Target

MT Newswires Live
·
Nov 13, 2025

LifeStance Health Group Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 08, 2025

UBS Adjusts Price Target on Lifestance Health Group to $10 From $9, Maintains Buy Rating

MT Newswires Live
·
Nov 08, 2025

Strong Performance and Promising Outlook: Richard Close Reaffirms Buy Rating for Lifestance Health Group

TIPRANKS
·
Nov 07, 2025

LifeStance Health Group Is Maintained at Buy by BTIG

Dow Jones
·
Nov 07, 2025